SelectQuote's Fiscal First Quarter 2027 Earnings Call - SELECTQUOTE INC

Explicit Guidance:

• Consolidated operating cash flow target of at least $60 million for Fiscal Year 2027.
• Healthcare services segment EBITDA margin target to double by the end of Fiscal 2027.
• Senior segment strategy to prioritize profitability over volume growth for Fiscal 2027 (AEP and OEP seasons), maintaining a smaller, tenured agent force.
• No explicit guidance provided for Fiscal 2028, but a path to paying the preferred dividend in cash is anticipated.
• Revenue decline expected to continue in Q2 (Fiscal 2027) as a seasonal investment quarter before cash flow ramps in the second half.

Business-Segment Outlook:

• Senior: Confidence in exceeding last year's recapture rate (which was 30% in FY2026); entering the season with >50% of beneficiaries experiencing terminations already contacted.
• Healthcare Services (SelectRx): Expectation to increase the percentage of scripts shipped from the Olathe, Kansas facility significantly by year-end; automation aims to complete enrollments 20% faster; EBITDA per member increased 60% YoY.
• Life Insurance: Continued focus on "attractive returns" for term life; Final Expense expected to maintain strong efficiency and margins despite a smaller agent force.
• Overall: Aiming to compound profitability and cash flow gains; expecting "brighter days" and a reemergence into responsible growth for Medicare Advantage as carrier profitability targets stabilize.

Market and Competitive Outlook:

• Medicare Advantage (MA): Industry viewed as nearing an inflection point as carriers "right-size" and align benefits with economic objectives; carriers reporting tracking ahead of target profitability.
• Recapture: Plan terminations and benefit disruptions expected to drive high beneficiary engagement, creating incremental commission opportunities.
• Carrier Behavior: Expectation of a "stable" commission environment and potential for carriers to increase marketing spend if margins improve; decisions on specific targeting can be made up to mid-to-late November.
• Product Mix: Anticipation of continued national player push into SNP (Special Needs Plans) and DSNP plans, aligning with platform strengths and driving velocity for SelectRx.

Macro / Industry Outlook:

• Inflation Reduction Act (IRA): Recognized as a multi-year drag on top-line revenue for Healthcare Services; however, impact on EBITDA is "far less significant" due to offsetting manufacturer reimbursements.
• Clean Comparisons: A full "clean" YoY comparison for IRA impact is not expected until Fiscal 2028 due to staggered drug pricing introductions.
• Industry Volatility: Continued market disruption expected in the current year, but conditions viewed as improving with "more healthiness" in payer MLRs and plan viability.

Strategic Initiatives:

• Technology & AI: Expansion of AI tools for call screening (currently >33% of calls), transcription, and coaching; deployment of "AI enrollment agent" to handle administrative lifting, freeing licensed agents for complex needs analysis.
• Pharmacy Management System (PMS): Implementation of a new integrated PMS to drive growth and efficiency; expected to shift more volume to the high-efficiency Olathe facility.
• Cost Reduction: Previously removed $30 million in permanent run-rate costs in FY2027; continued focus on efficiency to drive operating leverage.
• Capital Structure: Planned reverse stock split for November 10th shareholder approval to maintain NYSE listing; no capital raised.
• Capital Allocation: Long-term plan to use excess cash flow to reduce high-cost debt and eventually transition preferred dividend to cash payments.

Risks and Headwinds to Outlook:

• Medicare Advantage Volatility: Continued carrier benefit restructuring, plan terminations, and market disruption could impact volume; cautious hiring approach due to this dynamic environment.
• Regulatory Impact: The multi-year nature of the Inflation Reduction Act continues to suppress top-line revenue comparisons for Healthcare Services.
• Operational Execution: Reliance on the successful ramp of new agent tools and PMS integration; potential delays in transferring existing members to the Olathe facility.
• Carrier Marketing Decisions: Potential variability in carrier marketing budget changes (up to mid-November) could impact targeting efficiency.

Management Tone on the Future:

• Confidence Level: High; explicitly stated "highly confident" in the model and the ability to accelerate profitability when attractive opportunities emerge.
• Strategic Stance: Shift from pure growth to "cash efficiency" and "profitability" in the current environment, with a clear pivot to growth when carrier conditions improve.
• Valuation: Management believes stock remains "significantly undervalued."
• Hedges: Emphasis on a "nimble" agent model and technology flexibility to capitalize on opportunities without overextending on headcount during disruption.

Miscellaneous:

• Dividend: Explicitly stated no specific FY2028 guidance, but confirmed the intent to pay the preferred dividend in cash once cash flow levels rise further.
• Agent Productivity: Tenured agents (flat in number but larger mix vs. new hires) expected to perform ~2x the productivity of new agents.
• Facility Efficiency: Olathe facility running ~30% higher efficiency compared to legacy sites.